← Eichor
Study identifier: NCT07348692 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Condition: Pneumococcal Immunization · Healthy Volunteers  ·  Sponsor: Sanofi

PhasePhase 3
Planned participants2195
Who can joinAll sexes, 42 Days to 89 Days
Healthy volunteersYes

About this study

This is a phase 3 randomized, modified double-blind study whose purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) in a similar way (ie, same immune response) when they are given to infants aged from approximately 2 months (42 to 89 days) and are safe compared to a licensed 20-valent pneumococcal vaccine (20vPCV) (Prevnar 20™). The study duration per participant will be up to approximately 17 months. The study vaccines (either PCV21 or 20vPCV) will be administered at approximately 2, 4, 6 and 12 months of age. Cohort A will include randomization to three PCV21 formulation groups or one 20vPCV comparator group (Group 1-4, approximately 896 total participants), whereas Cohort B will include randomization to three PCV21 formulation groups only (Groups 1-3, approximately 1299 total participants). Routine pediatric vaccines will be given as per local recommendations. There will be 6 study visits: Visit (V)01, V02 separated from V01 by 60 days, V03 separated from V02 by 60 days, V04 separated from V03 by 30 days, V05 at 12 months of age, V06 separated from V05 by 30 days

This description comes directly from the study's public registry record.

Talk to the study team

Trial Transparency email recommended (Toll free for US & Canada)  ·  800-633-1610  ·  Contact-US@sanofi.com

Always discuss trial participation with your own doctor first.

Locations (19)

Northwest Arkansas Pediatric Clinic- Site Number : 8400039Fayetteville, Arkansas, United StatesRecruiting
Matrix Clinical Research - Huntington Park- Site Number : 8400029Huntington Park, California, United StatesRecruiting
Community Clinical Research- Site Number : 8400030Los Angeles, California, United StatesRecruiting
Matrix Clinical Research - Los Angeles- Site Number : 8400028Los Angeles, California, United StatesRecruiting
PAS Research - Tampa- Site Number : 8400034Tampa, Florida, United StatesRecruiting
Kentucky Pediatric Research- Site Number : 8400036Bardstown, Kentucky, United StatesRecruiting
Michigan Institute of Research- Site Number : 8400004Allen Park, Michigan, United StatesRecruiting
Tribe Clinical Research At Neighbors Pediatrics- Site Number : 8400008Charleston, South Carolina, United StatesRecruiting
Parkside Pediatrics - Simpsonville- Site Number : 8400005Simpsonville, South Carolina, United StatesRecruiting
Tribe Clinical Research - Spartanburg- Site Number : 8400026Spartanburg, South Carolina, United StatesRecruiting
PAS Research - Children's Care Clinic- Site Number : 8400035Edinburg, Texas, United StatesRecruiting
Pediatric Center - Richmond- Site Number : 8400038Richmond, Texas, United StatesRecruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07348692